Quiet on the insider front: nobody at Avid Bioservices, Inc. bought or sold CDMO shares with their own money this past year.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | Richieri Richard A. | Executive Officer | Sell | 2,283 | $12.37 | $28K | SEC |
| Jan 13, 2025 | Richieri Richard A. | Executive Officer | Sell | 200 | $12.37 | $2K | SEC |
| Dec 27, 2024 | Richieri Richard A. | Executive Officer | Sell | 3,843 | $12.22 | $47K | SEC |
| Dec 27, 2024 | Kwietniak Matthew R. | Executive Officer | Sell | 3,225 | $12.22 | $39K | SEC |
| Dec 27, 2024 | Kwietniak Matthew R. | Executive Officer | Sell | 10,165 | $12.22 | $124K | SEC |
| Dec 27, 2024 | Hart Daniel R | CFO | Sell | 20,845 | $12.22 | $255K | SEC |
| Dec 27, 2024 | Hart Daniel R | CFO | Sell | 1,968 | $12.22 | $24K | SEC |
| Dec 27, 2024 | Green Nicholas Stewart | CEO | Sell | 57,675 | $12.22 | $705K | SEC |
| Dec 27, 2024 | Green Nicholas Stewart | CEO | Sell | 88,236 | $12.22 | $1.1M | SEC |
| Dec 26, 2024 | Green Nicholas Stewart | CEO | Sell | 51,653 | $12.27 | $634K | SEC |
| Dec 26, 2024 | Green Nicholas Stewart | CEO | Sell | 75,000 | $12.31 | $923K | SEC |
| Dec 26, 2024 | Green Nicholas Stewart | CEO | Sell | 100,000 | $12.28 | $1.2M | SEC |
| Oct 15, 2024 | Kwietniak Matthew R. | Executive Officer | Sell | 119 | $10.15 | $1K | SEC |
| Oct 11, 2024 | Richieri Richard A. | Executive Officer | Sell | 201 | $10.05 | $2K | SEC |
| Oct 11, 2024 | Richieri Richard A. | Executive Officer | Sell | 2,031 | $10.05 | $20K | SEC |
There were no open-market insider trades in CDMO in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in CDMO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).